263 related articles for article (PubMed ID: 14960512)
21. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist.
Gillessen S; Carvajal D; Ling P; Podlaski FJ; Stremlo DL; Familletti PC; Gubler U; Presky DH; Stern AS; Gately MK
Eur J Immunol; 1995 Jan; 25(1):200-6. PubMed ID: 7843232
[TBL] [Abstract][Full Text] [Related]
22. The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.
Pfister K; Wittig BM; Jüngling B; Ecker KW; Barth S; Huhn M; Sasse S; Engert A; Mueller-Molaian I; Diehl V; Zeitz M; Stallmach A
Int J Colorectal Dis; 2002 Mar; 17(2):77-84. PubMed ID: 12014425
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis.
Fiorucci S; Distrutti E; Mencarelli A; Barbanti M; Palazzini E; Morelli A
Digestion; 2002; 66(4):246-56. PubMed ID: 12592101
[TBL] [Abstract][Full Text] [Related]
24. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.
Shimozato O; Ugai S; Chiyo M; Takenobu H; Nagakawa H; Wada A; Kawamura K; Yamamoto H; Tagawa M
Immunology; 2006 Jan; 117(1):22-8. PubMed ID: 16423037
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
[TBL] [Abstract][Full Text] [Related]
26. Characterization of an IL-12 p40/p35 Truncated Fusion Protein That can Inhibit the Action of IL-12.
Skrombolas D; Wylie I; Maharaj S; Frelinger JG
J Interferon Cytokine Res; 2015 Sep; 35(9):690-7. PubMed ID: 25938719
[TBL] [Abstract][Full Text] [Related]
27. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
28. IL-2-IgG2b fusion protein suppresses murine contact hypersensitivity in vivo.
Rückert R; Brandt K; Hofmann U; Bulfone-Paus S; Paus R
J Invest Dermatol; 2002 Aug; 119(2):370-6. PubMed ID: 12190859
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells.
Monteleone G; Biancone L; Marasco R; Morrone G; Marasco O; Luzza F; Pallone F
Gastroenterology; 1997 Apr; 112(4):1169-78. PubMed ID: 9098000
[TBL] [Abstract][Full Text] [Related]
30. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.
Fuss IJ; Marth T; Neurath MF; Pearlstein GR; Jain A; Strober W
Gastroenterology; 1999 Nov; 117(5):1078-88. PubMed ID: 10535870
[TBL] [Abstract][Full Text] [Related]
31. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
[TBL] [Abstract][Full Text] [Related]
32. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.
Ling P; Gately MK; Gubler U; Stern AS; Lin P; Hollfelder K; Su C; Pan YC; Hakimi J
J Immunol; 1995 Jan; 154(1):116-27. PubMed ID: 7527811
[TBL] [Abstract][Full Text] [Related]
33. N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.
Wen Q; Zhou L; Chen H; Zhang Y
J Gastroenterol Hepatol; 2013 Aug; 28(8):1330-8. PubMed ID: 23663055
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
35. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
36. IL-12 p40 prevents the development of chronic enterocolitis in IL-10-deficient mice.
Shiraki M; Aihara H; Kinouchi Y; Takahashi S; Oki M; Noguchi M; Takahashi K; Miyazaki J; Shimosegawa T
Lab Invest; 2004 Nov; 84(11):1491-500. PubMed ID: 15448706
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo.
Gately MK; Carvajal DM; Connaughton SE; Gillessen S; Warrier RR; Kolinsky KD; Wilkinson VL; Dwyer CM; Higgins GF; Podlaski FJ; Faherty DA; Familletti PC; Stern AS; Presky DH
Ann N Y Acad Sci; 1996 Oct; 795():1-12. PubMed ID: 8958912
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo.
Holtmann MH; Douni E; Schütz M; Zeller G; Mudter J; Lehr HA; Gerspach J; Scheurich P; Galle PR; Kollias G; Neurath MF
Eur J Immunol; 2002 Nov; 32(11):3142-51. PubMed ID: 12555659
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor.
Jin HT; Youn JI; Kim HJ; Lee JB; Ha SJ; Koh JS; Sung YC
Hum Gene Ther; 2005 Mar; 16(3):328-38. PubMed ID: 15812228
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 19 reduces inflammation in chemically induced experimental colitis.
Matsuo Y; Azuma YT; Kuwamura M; Kuramoto N; Nishiyama K; Yoshida N; Ikeda Y; Fujimoto Y; Nakajima H; Takeuchi T
Int Immunopharmacol; 2015 Dec; 29(2):468-475. PubMed ID: 26476684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
